Impact of COVID-19 Outbreak on Off-body Wearable Injectors, Global Market Research Report 2020
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Off-body Wearable Injectors market in 2020.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Off-body Wearable Injectors industry.
Segment by Type
The report offers in-depth assessment of the growth and other aspects of the Off-body Wearable Injectors market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Off-body Wearable Injectors Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.
The major players in the market include Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group, West Pharmaceutical Services, Unilife, CeQur, Sensile Medical, Roche, ScPharmaceuticals, SteadyMed, etc.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Off-body Wearable Injectors market in 2020.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Off-body Wearable Injectors industry.
Segment by Type
- Electronical Injectors
- Mechanical Injectors
- Others
- Immuno-oncology
- Diabetes
- Cardiovascular Diseases
- Other
The report offers in-depth assessment of the growth and other aspects of the Off-body Wearable Injectors market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Off-body Wearable Injectors Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.
The major players in the market include Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group, West Pharmaceutical Services, Unilife, CeQur, Sensile Medical, Roche, ScPharmaceuticals, SteadyMed, etc.
1 OFF-BODY WEARABLE INJECTORS MARKET OVERVIEW
1.1 Product Overview and Scope of Off-body Wearable Injectors
1.2 Covid-19 Impact on Off-body Wearable Injectors Segment by Type
1.2.1 Global Off-body Wearable Injectors Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Covid-19 Impact on Off-body Wearable Injectors Segment by Application
1.3.1 Off-body Wearable Injectors Consumption Comparison by Application: 2020 VS 2026
1.3.2 Immuno-oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Covid-19 Impact on Global Off-body Wearable Injectors Market by Region
1.4.1 Global Off-body Wearable Injectors Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Covid-19 Impact on Global Off-body Wearable Injectors Growth Prospects
1.5.1 Global Off-body Wearable Injectors Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Off-body Wearable Injectors Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Off-body Wearable Injectors Production Estimates and Forecasts (2015-2026)
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 The Covid-19 Impact on Off-body Wearable Injectors Industry
1.8 COVID-19 Impact: Off-body Wearable Injectors Market Trends
2 COVID-19 IMPACT ON MARKET COMPETITION BY MANUFACTURERS
2.1 Global Off-body Wearable Injectors Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Off-body Wearable Injectors Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Off-body Wearable Injectors Average Price by Manufacturers (2015-2020)
2.5 Manufacturers Off-body Wearable Injectors Production Sites, Area Served, Product Types
2.6 Off-body Wearable Injectors Market Competitive Situation and Trends
2.6.1 Off-body Wearable Injectors Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 COVID-19 IMPACT ON PRODUCTION AND CAPACITY BY REGION
3.1 Global Production Capacity of Off-body Wearable Injectors Market Share by Regions (2015-2020)
3.2 Global Off-body Wearable Injectors Revenue Market Share by Regions (2015-2020)
3.3 Global Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America Off-body Wearable Injectors Production
3.4.1 North America Off-body Wearable Injectors Production Growth Rate (2015-2020)
3.4.2 North America Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Off-body Wearable Injectors Production
3.5.1 Europe Off-body Wearable Injectors Production Growth Rate (2015-2020)
3.5.2 Europe Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China Off-body Wearable Injectors Production
3.6.1 China Off-body Wearable Injectors Production Growth Rate (2015-2020)
3.6.2 China Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan Off-body Wearable Injectors Production
3.7.1 Japan Off-body Wearable Injectors Production Growth Rate (2015-2020)
3.7.2 Japan Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 COVID-19 IMPACT ON GLOBAL OFF-BODY WEARABLE INJECTORS CONSUMPTION BY REGIONS
4.1 Global Off-body Wearable Injectors Consumption by Regions
4.1.1 Global Off-body Wearable Injectors Consumption by Region
4.1.2 Global Off-body Wearable Injectors Consumption Market Share by Region
4.2 North America
4.2.1 North America Off-body Wearable Injectors Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Off-body Wearable Injectors Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Off-body Wearable Injectors Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Off-body Wearable Injectors Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil
5 COVID-19 IMPACT ON OFF-BODY WEARABLE INJECTORS PRODUCTION, REVENUE, PRICE TREND BY TYPE
5.1 Global Off-body Wearable Injectors Production Market Share by Type (2015-2020)
5.2 Global Off-body Wearable Injectors Revenue Market Share by Type (2015-2020)
5.3 Global Off-body Wearable Injectors Price by Type (2015-2020)
5.4 Global Off-body Wearable Injectors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 COVID-19 IMPACT ON GLOBAL OFF-BODY WEARABLE INJECTORS MARKET ANALYSIS BY APPLICATION
6.1 Global Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
6.2 Global Off-body Wearable Injectors Consumption Growth Rate by Application (2015-2020)
7 COVID-19 IMPACT ON COMPANY PROFILES AND KEY FIGURES IN OFF-BODY WEARABLE INJECTORS BUSINESS
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Off-body Wearable Injectors Production Sites and Area Served
7.1.2 Becton, Dickinson and Company Off-body Wearable Injectors Product Introduction, Application and Specification
7.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Becton, Dickinson and Company Main Business and Markets Served
7.2 Medtronic
7.2.1 Medtronic Off-body Wearable Injectors Production Sites and Area Served
7.2.2 Medtronic Off-body Wearable Injectors Product Introduction, Application and Specification
7.2.3 Medtronic Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Medtronic Main Business and Markets Served
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Off-body Wearable Injectors Production Sites and Area Served
7.3.2 Johnson & Johnson Off-body Wearable Injectors Product Introduction, Application and Specification
7.3.3 Johnson & Johnson Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Johnson & Johnson Main Business and Markets Served
7.4 Insulet Corporation
7.4.1 Insulet Corporation Off-body Wearable Injectors Production Sites and Area Served
7.4.2 Insulet Corporation Off-body Wearable Injectors Product Introduction, Application and Specification
7.4.3 Insulet Corporation Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Insulet Corporation Main Business and Markets Served
7.5 Unilife Corporation
7.5.1 Unilife Corporation Off-body Wearable Injectors Production Sites and Area Served
7.5.2 Unilife Corporation Off-body Wearable Injectors Product Introduction, Application and Specification
7.5.3 Unilife Corporation Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Unilife Corporation Main Business and Markets Served
7.6 Enable Injections
7.6.1 Enable Injections Off-body Wearable Injectors Production Sites and Area Served
7.6.2 Enable Injections Off-body Wearable Injectors Product Introduction, Application and Specification
7.6.3 Enable Injections Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Enable Injections Main Business and Markets Served
7.7 SteadyMed
7.7.1 SteadyMed Off-body Wearable Injectors Production Sites and Area Served
7.7.2 SteadyMed Off-body Wearable Injectors Product Introduction, Application and Specification
7.7.3 SteadyMed Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.7.4 SteadyMed Main Business and Markets Served
7.8 Ypsomed Group
7.8.1 Ypsomed Group Off-body Wearable Injectors Production Sites and Area Served
7.8.2 Ypsomed Group Off-body Wearable Injectors Product Introduction, Application and Specification
7.8.3 Ypsomed Group Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 Ypsomed Group Main Business and Markets Served
7.9 West Pharmaceutical Services
7.9.1 West Pharmaceutical Services Off-body Wearable Injectors Production Sites and Area Served
7.9.2 West Pharmaceutical Services Off-body Wearable Injectors Product Introduction, Application and Specification
7.9.3 West Pharmaceutical Services Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 West Pharmaceutical Services Main Business and Markets Served
7.10 Unilife
7.10.1 Unilife Off-body Wearable Injectors Production Sites and Area Served
7.10.2 Unilife Off-body Wearable Injectors Product Introduction, Application and Specification
7.10.3 Unilife Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 Unilife Main Business and Markets Served
7.11 CeQur
7.11.1 CeQur Off-body Wearable Injectors Production Sites and Area Served
7.11.2 CeQur Off-body Wearable Injectors Product Introduction, Application and Specification
7.11.3 CeQur Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 CeQur Main Business and Markets Served
7.12 Sensile Medical
7.12.1 Sensile Medical Off-body Wearable Injectors Production Sites and Area Served
7.12.2 Sensile Medical Off-body Wearable Injectors Product Introduction, Application and Specification
7.12.3 Sensile Medical Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.12.4 Sensile Medical Main Business and Markets Served
7.13 Roche
7.13.1 Roche Off-body Wearable Injectors Production Sites and Area Served
7.13.2 Roche Off-body Wearable Injectors Product Introduction, Application and Specification
7.13.3 Roche Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.13.4 Roche Main Business and Markets Served
7.14 ScPharmaceuticals
7.14.1 ScPharmaceuticals Off-body Wearable Injectors Production Sites and Area Served
7.14.2 ScPharmaceuticals Off-body Wearable Injectors Product Introduction, Application and Specification
7.14.3 ScPharmaceuticals Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.14.4 ScPharmaceuticals Main Business and Markets Served
7.15 SteadyMed
7.15.1 SteadyMed Off-body Wearable Injectors Production Sites and Area Served
7.15.2 SteadyMed Off-body Wearable Injectors Product Introduction, Application and Specification
7.15.3 SteadyMed Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.15.4 SteadyMed Main Business and Markets Served
8 OFF-BODY WEARABLE INJECTORS MANUFACTURING COST ANALYSIS
8.1 Off-body Wearable Injectors Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Off-body Wearable Injectors
8.4 Off-body Wearable Injectors Industrial Chain Analysis
9 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
9.1 Marketing Channel
9.2 Off-body Wearable Injectors Distributors List
9.3 Off-body Wearable Injectors Customers
10 MARKET DYNAMICS
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis
11 PRODUCTION AND SUPPLY FORECAST
11.1 Global Forecasted Production of Off-body Wearable Injectors (2021-2026)
11.2 Global Forecasted Revenue of Off-body Wearable Injectors (2021-2026)
11.3 Global Forecasted Price of Off-body Wearable Injectors (2021-2026)
11.4 Global Off-body Wearable Injectors Production Forecast by Regions (2021-2026)
11.4.1 North America Off-body Wearable Injectors Production, Revenue Forecast (2021-2026)
11.4.2 Europe Off-body Wearable Injectors Production, Revenue Forecast (2021-2026)
11.4.3 China Off-body Wearable Injectors Production, Revenue Forecast (2021-2026)
11.4.4 Japan Off-body Wearable Injectors Production, Revenue Forecast (2021-2026)
12 CONSUMPTION AND DEMAND FORECAST
12.1 Global Forecasted and Consumption Demand Analysis of Off-body Wearable Injectors
12.2 North America Forecasted Consumption of Off-body Wearable Injectors by Country
12.3 Europe Market Forecasted Consumption of Off-body Wearable Injectors by Country
12.4 Asia Pacific Market Forecasted Consumption of Off-body Wearable Injectors by Regions
12.5 Latin America Forecasted Consumption of Off-body Wearable Injectors
13 FORECAST BY TYPE AND BY APPLICATION (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of Off-body Wearable Injectors by Type (2021-2026)
13.1.2 Global Forecasted Revenue of Off-body Wearable Injectors by Type (2021-2026)
13.1.2 Global Forecasted Price of Off-body Wearable Injectors by Type (2021-2026)
13.2 Global Forecasted Consumption of Off-body Wearable Injectors by Application (2021-2026)
14 RESEARCH FINDING AND CONCLUSION
15 METHODOLOGY AND DATA SOURCE
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
1.1 Product Overview and Scope of Off-body Wearable Injectors
1.2 Covid-19 Impact on Off-body Wearable Injectors Segment by Type
1.2.1 Global Off-body Wearable Injectors Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Covid-19 Impact on Off-body Wearable Injectors Segment by Application
1.3.1 Off-body Wearable Injectors Consumption Comparison by Application: 2020 VS 2026
1.3.2 Immuno-oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Covid-19 Impact on Global Off-body Wearable Injectors Market by Region
1.4.1 Global Off-body Wearable Injectors Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Covid-19 Impact on Global Off-body Wearable Injectors Growth Prospects
1.5.1 Global Off-body Wearable Injectors Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Off-body Wearable Injectors Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Off-body Wearable Injectors Production Estimates and Forecasts (2015-2026)
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 The Covid-19 Impact on Off-body Wearable Injectors Industry
1.8 COVID-19 Impact: Off-body Wearable Injectors Market Trends
2 COVID-19 IMPACT ON MARKET COMPETITION BY MANUFACTURERS
2.1 Global Off-body Wearable Injectors Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Off-body Wearable Injectors Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Off-body Wearable Injectors Average Price by Manufacturers (2015-2020)
2.5 Manufacturers Off-body Wearable Injectors Production Sites, Area Served, Product Types
2.6 Off-body Wearable Injectors Market Competitive Situation and Trends
2.6.1 Off-body Wearable Injectors Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 COVID-19 IMPACT ON PRODUCTION AND CAPACITY BY REGION
3.1 Global Production Capacity of Off-body Wearable Injectors Market Share by Regions (2015-2020)
3.2 Global Off-body Wearable Injectors Revenue Market Share by Regions (2015-2020)
3.3 Global Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America Off-body Wearable Injectors Production
3.4.1 North America Off-body Wearable Injectors Production Growth Rate (2015-2020)
3.4.2 North America Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Off-body Wearable Injectors Production
3.5.1 Europe Off-body Wearable Injectors Production Growth Rate (2015-2020)
3.5.2 Europe Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China Off-body Wearable Injectors Production
3.6.1 China Off-body Wearable Injectors Production Growth Rate (2015-2020)
3.6.2 China Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan Off-body Wearable Injectors Production
3.7.1 Japan Off-body Wearable Injectors Production Growth Rate (2015-2020)
3.7.2 Japan Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 COVID-19 IMPACT ON GLOBAL OFF-BODY WEARABLE INJECTORS CONSUMPTION BY REGIONS
4.1 Global Off-body Wearable Injectors Consumption by Regions
4.1.1 Global Off-body Wearable Injectors Consumption by Region
4.1.2 Global Off-body Wearable Injectors Consumption Market Share by Region
4.2 North America
4.2.1 North America Off-body Wearable Injectors Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Off-body Wearable Injectors Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Off-body Wearable Injectors Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Off-body Wearable Injectors Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil
5 COVID-19 IMPACT ON OFF-BODY WEARABLE INJECTORS PRODUCTION, REVENUE, PRICE TREND BY TYPE
5.1 Global Off-body Wearable Injectors Production Market Share by Type (2015-2020)
5.2 Global Off-body Wearable Injectors Revenue Market Share by Type (2015-2020)
5.3 Global Off-body Wearable Injectors Price by Type (2015-2020)
5.4 Global Off-body Wearable Injectors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 COVID-19 IMPACT ON GLOBAL OFF-BODY WEARABLE INJECTORS MARKET ANALYSIS BY APPLICATION
6.1 Global Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
6.2 Global Off-body Wearable Injectors Consumption Growth Rate by Application (2015-2020)
7 COVID-19 IMPACT ON COMPANY PROFILES AND KEY FIGURES IN OFF-BODY WEARABLE INJECTORS BUSINESS
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Off-body Wearable Injectors Production Sites and Area Served
7.1.2 Becton, Dickinson and Company Off-body Wearable Injectors Product Introduction, Application and Specification
7.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Becton, Dickinson and Company Main Business and Markets Served
7.2 Medtronic
7.2.1 Medtronic Off-body Wearable Injectors Production Sites and Area Served
7.2.2 Medtronic Off-body Wearable Injectors Product Introduction, Application and Specification
7.2.3 Medtronic Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Medtronic Main Business and Markets Served
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Off-body Wearable Injectors Production Sites and Area Served
7.3.2 Johnson & Johnson Off-body Wearable Injectors Product Introduction, Application and Specification
7.3.3 Johnson & Johnson Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Johnson & Johnson Main Business and Markets Served
7.4 Insulet Corporation
7.4.1 Insulet Corporation Off-body Wearable Injectors Production Sites and Area Served
7.4.2 Insulet Corporation Off-body Wearable Injectors Product Introduction, Application and Specification
7.4.3 Insulet Corporation Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Insulet Corporation Main Business and Markets Served
7.5 Unilife Corporation
7.5.1 Unilife Corporation Off-body Wearable Injectors Production Sites and Area Served
7.5.2 Unilife Corporation Off-body Wearable Injectors Product Introduction, Application and Specification
7.5.3 Unilife Corporation Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Unilife Corporation Main Business and Markets Served
7.6 Enable Injections
7.6.1 Enable Injections Off-body Wearable Injectors Production Sites and Area Served
7.6.2 Enable Injections Off-body Wearable Injectors Product Introduction, Application and Specification
7.6.3 Enable Injections Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Enable Injections Main Business and Markets Served
7.7 SteadyMed
7.7.1 SteadyMed Off-body Wearable Injectors Production Sites and Area Served
7.7.2 SteadyMed Off-body Wearable Injectors Product Introduction, Application and Specification
7.7.3 SteadyMed Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.7.4 SteadyMed Main Business and Markets Served
7.8 Ypsomed Group
7.8.1 Ypsomed Group Off-body Wearable Injectors Production Sites and Area Served
7.8.2 Ypsomed Group Off-body Wearable Injectors Product Introduction, Application and Specification
7.8.3 Ypsomed Group Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 Ypsomed Group Main Business and Markets Served
7.9 West Pharmaceutical Services
7.9.1 West Pharmaceutical Services Off-body Wearable Injectors Production Sites and Area Served
7.9.2 West Pharmaceutical Services Off-body Wearable Injectors Product Introduction, Application and Specification
7.9.3 West Pharmaceutical Services Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 West Pharmaceutical Services Main Business and Markets Served
7.10 Unilife
7.10.1 Unilife Off-body Wearable Injectors Production Sites and Area Served
7.10.2 Unilife Off-body Wearable Injectors Product Introduction, Application and Specification
7.10.3 Unilife Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 Unilife Main Business and Markets Served
7.11 CeQur
7.11.1 CeQur Off-body Wearable Injectors Production Sites and Area Served
7.11.2 CeQur Off-body Wearable Injectors Product Introduction, Application and Specification
7.11.3 CeQur Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 CeQur Main Business and Markets Served
7.12 Sensile Medical
7.12.1 Sensile Medical Off-body Wearable Injectors Production Sites and Area Served
7.12.2 Sensile Medical Off-body Wearable Injectors Product Introduction, Application and Specification
7.12.3 Sensile Medical Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.12.4 Sensile Medical Main Business and Markets Served
7.13 Roche
7.13.1 Roche Off-body Wearable Injectors Production Sites and Area Served
7.13.2 Roche Off-body Wearable Injectors Product Introduction, Application and Specification
7.13.3 Roche Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.13.4 Roche Main Business and Markets Served
7.14 ScPharmaceuticals
7.14.1 ScPharmaceuticals Off-body Wearable Injectors Production Sites and Area Served
7.14.2 ScPharmaceuticals Off-body Wearable Injectors Product Introduction, Application and Specification
7.14.3 ScPharmaceuticals Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.14.4 ScPharmaceuticals Main Business and Markets Served
7.15 SteadyMed
7.15.1 SteadyMed Off-body Wearable Injectors Production Sites and Area Served
7.15.2 SteadyMed Off-body Wearable Injectors Product Introduction, Application and Specification
7.15.3 SteadyMed Off-body Wearable Injectors Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.15.4 SteadyMed Main Business and Markets Served
8 OFF-BODY WEARABLE INJECTORS MANUFACTURING COST ANALYSIS
8.1 Off-body Wearable Injectors Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Off-body Wearable Injectors
8.4 Off-body Wearable Injectors Industrial Chain Analysis
9 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
9.1 Marketing Channel
9.2 Off-body Wearable Injectors Distributors List
9.3 Off-body Wearable Injectors Customers
10 MARKET DYNAMICS
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis
11 PRODUCTION AND SUPPLY FORECAST
11.1 Global Forecasted Production of Off-body Wearable Injectors (2021-2026)
11.2 Global Forecasted Revenue of Off-body Wearable Injectors (2021-2026)
11.3 Global Forecasted Price of Off-body Wearable Injectors (2021-2026)
11.4 Global Off-body Wearable Injectors Production Forecast by Regions (2021-2026)
11.4.1 North America Off-body Wearable Injectors Production, Revenue Forecast (2021-2026)
11.4.2 Europe Off-body Wearable Injectors Production, Revenue Forecast (2021-2026)
11.4.3 China Off-body Wearable Injectors Production, Revenue Forecast (2021-2026)
11.4.4 Japan Off-body Wearable Injectors Production, Revenue Forecast (2021-2026)
12 CONSUMPTION AND DEMAND FORECAST
12.1 Global Forecasted and Consumption Demand Analysis of Off-body Wearable Injectors
12.2 North America Forecasted Consumption of Off-body Wearable Injectors by Country
12.3 Europe Market Forecasted Consumption of Off-body Wearable Injectors by Country
12.4 Asia Pacific Market Forecasted Consumption of Off-body Wearable Injectors by Regions
12.5 Latin America Forecasted Consumption of Off-body Wearable Injectors
13 FORECAST BY TYPE AND BY APPLICATION (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of Off-body Wearable Injectors by Type (2021-2026)
13.1.2 Global Forecasted Revenue of Off-body Wearable Injectors by Type (2021-2026)
13.1.2 Global Forecasted Price of Off-body Wearable Injectors by Type (2021-2026)
13.2 Global Forecasted Consumption of Off-body Wearable Injectors by Application (2021-2026)
14 RESEARCH FINDING AND CONCLUSION
15 METHODOLOGY AND DATA SOURCE
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
LIST OF TABLES
Table 1. Global Off-body Wearable Injectors Production (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Off-body Wearable Injectors Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 3. Global Off-body Wearable Injectors Consumption (K Units) Comparison by Application: 2020 VS 2026
Table 4. COVID-19 Impact Global Market: (Four Off-body Wearable Injectors Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Off-body Wearable Injectors Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Off-body Wearable Injectors Players to Combat Covid-19 Impact
Table 9. Global Off-body Wearable Injectors Production (K Units) by Manufacturers
Table 10. Global Off-body Wearable Injectors Production (K Units) by Manufacturers (2015-2020)
Table 11. Global Off-body Wearable Injectors Production Share by Manufacturers (2015-2020)
Table 12. Global Off-body Wearable Injectors Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Off-body Wearable Injectors Revenue Share by Manufacturers (2015-2020)
Table 14. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Off-body Wearable Injectors as of 2019)
Table 15. Global Market Off-body Wearable Injectors Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 16. Manufacturers Off-body Wearable Injectors Production Sites and Area Served
Table 17. Manufacturers Off-body Wearable Injectors Product Types
Table 18. Global Off-body Wearable Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Off-body Wearable Injectors Capacity (K Units) by Region (2015-2020)
Table 21. Global Off-body Wearable Injectors Production (K Units) by Region (2015-2020)
Table 22. Global Off-body Wearable Injectors Revenue (Million US$) by Region (2015-2020)
Table 23. Global Off-body Wearable Injectors Revenue Market Share by Region (2015-2020)
Table 24. Global Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 25. North America Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 26. Europe Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 27. China Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 28. Japan Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 29. Global Off-body Wearable Injectors Consumption (K Units) Market by Region (2015-2020)
Table 30. Global Off-body Wearable Injectors Consumption Market Share by Region (2015-2020)
Table 31. North America Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 32. Europe Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 33. Asia Pacific Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 34. Latin America Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 35. Global Off-body Wearable Injectors Production (K Units) by Type (2015-2020)
Table 36. Global Off-body Wearable Injectors Production Share by Type (2015-2020)
Table 37. Global Off-body Wearable Injectors Revenue (Million US$) by Type (2015-2020)
Table 38. Global Off-body Wearable Injectors Revenue Share by Type (2015-2020)
Table 39. Global Off-body Wearable Injectors Price (US$/Unit) by Type (2015-2020)
Table 40. Global Off-body Wearable Injectors Consumption (K Units) by Application (2015-2020)
Table 41. Global Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
Table 42. Global Off-body Wearable Injectors Consumption Growth Rate by Application (2015-2020)
Table 43. Becton, Dickinson and Company Off-body Wearable Injectors Production Sites and Area Served
Table 44. Becton, Dickinson and Company Production Sites and Area Served
Table 45. Becton, Dickinson and Company Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 46. Becton, Dickinson and Company Main Business and Markets Served
Table 47. Medtronic Off-body Wearable Injectors Production Sites and Area Served
Table 48. Medtronic Production Sites and Area Served
Table 49. Medtronic Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 50. Medtronic Main Business and Markets Served
Table 51. Johnson & Johnson Off-body Wearable Injectors Production Sites and Area Served
Table 52. Johnson & Johnson Production Sites and Area Served
Table 53. Johnson & Johnson Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 54. Johnson & Johnson Main Business and Markets Served
Table 55. Insulet Corporation Off-body Wearable Injectors Production Sites and Area Served
Table 56. Insulet Corporation Production Sites and Area Served
Table 57. Insulet Corporation Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 58. Insulet Corporation Main Business and Markets Served
Table 59. Unilife Corporation Off-body Wearable Injectors Production Sites and Area Served
Table 60. Unilife Corporation Production Sites and Area Served
Table 61. Unilife Corporation Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 62. Unilife Corporation Main Business and Markets Served
Table 63. Enable Injections Off-body Wearable Injectors Production Sites and Area Served
Table 64. Enable Injections Production Sites and Area Served
Table 65. Enable Injections Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Enable Injections Main Business and Markets Served
Table 67. SteadyMed Off-body Wearable Injectors Production Sites and Area Served
Table 68. SteadyMed Production Sites and Area Served
Table 69. SteadyMed Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 70. SteadyMed Main Business and Markets Served
Table 71. Ypsomed Group Off-body Wearable Injectors Production Sites and Area Served
Table 72. Ypsomed Group Production Sites and Area Served
Table 73. Ypsomed Group Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 74. Ypsomed Group Main Business and Markets Served
Table 75. West Pharmaceutical Services Off-body Wearable Injectors Production Sites and Area Served
Table 76. West Pharmaceutical Services Production Sites and Area Served
Table 77. West Pharmaceutical Services Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 78. West Pharmaceutical Services Main Business and Markets Served
Table 79. Unilife Off-body Wearable Injectors Production Sites and Area Served
Table 80. Unilife Production Sites and Area Served
Table 81. Unilife Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 82. Unilife Main Business and Markets Served
Table 83. CeQur Off-body Wearable Injectors Production Sites and Area Served
Table 84. CeQur Production Sites and Area Served
Table 85. CeQur Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. CeQur Main Business and Markets Served
Table 87. Sensile Medical Off-body Wearable Injectors Production Sites and Area Served
Table 88. Sensile Medical Production Sites and Area Served
Table 89. Sensile Medical Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 90. Sensile Medical Main Business and Markets Served
Table 91. Roche Off-body Wearable Injectors Production Sites and Area Served
Table 92. Roche Production Sites and Area Served
Table 93. Roche Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 94. Roche Main Business and Markets Served
Table 95. ScPharmaceuticals Off-body Wearable Injectors Production Sites and Area Served
Table 96. ScPharmaceuticals Production Sites and Area Served
Table 97. ScPharmaceuticals Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 98. ScPharmaceuticals Main Business and Markets Served
Table 99. SteadyMed Off-body Wearable Injectors Production Sites and Area Served
Table 100. SteadyMed Production Sites and Area Served
Table 101. SteadyMed Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 102. SteadyMed Main Business and Markets Served
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Off-body Wearable Injectors Distributors List
Table 106. Off-body Wearable Injectors Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Off-body Wearable Injectors Production (K Units) Forecast by Region (2021-2026)
Table 111. North America Off-body Wearable Injectors Consumption Forecast 2021-2026 (K Units) by Country
Table 112. Europe Off-body Wearable Injectors Consumption Forecast 2021-2026 (K Units) by Country
Table 113. Asia Pacific Off-body Wearable Injectors Consumption Forecast 2021-2026 (K Units) by Regions
Table 114. Latin America Off-body Wearable Injectors Consumption Forecast 2021-2026 (K Units) by Country
Table 115. Global Off-body Wearable Injectors Consumption (K Units) Forecast by Regions (2021-2026)
Table 116. Global Off-body Wearable Injectors Production (K Units) Forecast by Type (2021-2026)
Table 117. Global Off-body Wearable Injectors Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Off-body Wearable Injectors Price (US$/Unit) Forecast by Type (2021-2026)
Table 119. Global Off-body Wearable Injectors Consumption (K Units) Forecast by Application (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 1. Global Off-body Wearable Injectors Production (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Off-body Wearable Injectors Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 3. Global Off-body Wearable Injectors Consumption (K Units) Comparison by Application: 2020 VS 2026
Table 4. COVID-19 Impact Global Market: (Four Off-body Wearable Injectors Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Off-body Wearable Injectors Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Off-body Wearable Injectors Players to Combat Covid-19 Impact
Table 9. Global Off-body Wearable Injectors Production (K Units) by Manufacturers
Table 10. Global Off-body Wearable Injectors Production (K Units) by Manufacturers (2015-2020)
Table 11. Global Off-body Wearable Injectors Production Share by Manufacturers (2015-2020)
Table 12. Global Off-body Wearable Injectors Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Off-body Wearable Injectors Revenue Share by Manufacturers (2015-2020)
Table 14. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Off-body Wearable Injectors as of 2019)
Table 15. Global Market Off-body Wearable Injectors Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 16. Manufacturers Off-body Wearable Injectors Production Sites and Area Served
Table 17. Manufacturers Off-body Wearable Injectors Product Types
Table 18. Global Off-body Wearable Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Off-body Wearable Injectors Capacity (K Units) by Region (2015-2020)
Table 21. Global Off-body Wearable Injectors Production (K Units) by Region (2015-2020)
Table 22. Global Off-body Wearable Injectors Revenue (Million US$) by Region (2015-2020)
Table 23. Global Off-body Wearable Injectors Revenue Market Share by Region (2015-2020)
Table 24. Global Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 25. North America Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 26. Europe Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 27. China Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 28. Japan Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 29. Global Off-body Wearable Injectors Consumption (K Units) Market by Region (2015-2020)
Table 30. Global Off-body Wearable Injectors Consumption Market Share by Region (2015-2020)
Table 31. North America Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 32. Europe Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 33. Asia Pacific Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 34. Latin America Off-body Wearable Injectors Consumption by Countries (2015-2020) (K Units)
Table 35. Global Off-body Wearable Injectors Production (K Units) by Type (2015-2020)
Table 36. Global Off-body Wearable Injectors Production Share by Type (2015-2020)
Table 37. Global Off-body Wearable Injectors Revenue (Million US$) by Type (2015-2020)
Table 38. Global Off-body Wearable Injectors Revenue Share by Type (2015-2020)
Table 39. Global Off-body Wearable Injectors Price (US$/Unit) by Type (2015-2020)
Table 40. Global Off-body Wearable Injectors Consumption (K Units) by Application (2015-2020)
Table 41. Global Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
Table 42. Global Off-body Wearable Injectors Consumption Growth Rate by Application (2015-2020)
Table 43. Becton, Dickinson and Company Off-body Wearable Injectors Production Sites and Area Served
Table 44. Becton, Dickinson and Company Production Sites and Area Served
Table 45. Becton, Dickinson and Company Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 46. Becton, Dickinson and Company Main Business and Markets Served
Table 47. Medtronic Off-body Wearable Injectors Production Sites and Area Served
Table 48. Medtronic Production Sites and Area Served
Table 49. Medtronic Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 50. Medtronic Main Business and Markets Served
Table 51. Johnson & Johnson Off-body Wearable Injectors Production Sites and Area Served
Table 52. Johnson & Johnson Production Sites and Area Served
Table 53. Johnson & Johnson Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 54. Johnson & Johnson Main Business and Markets Served
Table 55. Insulet Corporation Off-body Wearable Injectors Production Sites and Area Served
Table 56. Insulet Corporation Production Sites and Area Served
Table 57. Insulet Corporation Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 58. Insulet Corporation Main Business and Markets Served
Table 59. Unilife Corporation Off-body Wearable Injectors Production Sites and Area Served
Table 60. Unilife Corporation Production Sites and Area Served
Table 61. Unilife Corporation Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 62. Unilife Corporation Main Business and Markets Served
Table 63. Enable Injections Off-body Wearable Injectors Production Sites and Area Served
Table 64. Enable Injections Production Sites and Area Served
Table 65. Enable Injections Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Enable Injections Main Business and Markets Served
Table 67. SteadyMed Off-body Wearable Injectors Production Sites and Area Served
Table 68. SteadyMed Production Sites and Area Served
Table 69. SteadyMed Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 70. SteadyMed Main Business and Markets Served
Table 71. Ypsomed Group Off-body Wearable Injectors Production Sites and Area Served
Table 72. Ypsomed Group Production Sites and Area Served
Table 73. Ypsomed Group Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 74. Ypsomed Group Main Business and Markets Served
Table 75. West Pharmaceutical Services Off-body Wearable Injectors Production Sites and Area Served
Table 76. West Pharmaceutical Services Production Sites and Area Served
Table 77. West Pharmaceutical Services Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 78. West Pharmaceutical Services Main Business and Markets Served
Table 79. Unilife Off-body Wearable Injectors Production Sites and Area Served
Table 80. Unilife Production Sites and Area Served
Table 81. Unilife Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 82. Unilife Main Business and Markets Served
Table 83. CeQur Off-body Wearable Injectors Production Sites and Area Served
Table 84. CeQur Production Sites and Area Served
Table 85. CeQur Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. CeQur Main Business and Markets Served
Table 87. Sensile Medical Off-body Wearable Injectors Production Sites and Area Served
Table 88. Sensile Medical Production Sites and Area Served
Table 89. Sensile Medical Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 90. Sensile Medical Main Business and Markets Served
Table 91. Roche Off-body Wearable Injectors Production Sites and Area Served
Table 92. Roche Production Sites and Area Served
Table 93. Roche Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 94. Roche Main Business and Markets Served
Table 95. ScPharmaceuticals Off-body Wearable Injectors Production Sites and Area Served
Table 96. ScPharmaceuticals Production Sites and Area Served
Table 97. ScPharmaceuticals Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 98. ScPharmaceuticals Main Business and Markets Served
Table 99. SteadyMed Off-body Wearable Injectors Production Sites and Area Served
Table 100. SteadyMed Production Sites and Area Served
Table 101. SteadyMed Off-body Wearable Injectors Production Capacity (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 102. SteadyMed Main Business and Markets Served
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Off-body Wearable Injectors Distributors List
Table 106. Off-body Wearable Injectors Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Off-body Wearable Injectors Production (K Units) Forecast by Region (2021-2026)
Table 111. North America Off-body Wearable Injectors Consumption Forecast 2021-2026 (K Units) by Country
Table 112. Europe Off-body Wearable Injectors Consumption Forecast 2021-2026 (K Units) by Country
Table 113. Asia Pacific Off-body Wearable Injectors Consumption Forecast 2021-2026 (K Units) by Regions
Table 114. Latin America Off-body Wearable Injectors Consumption Forecast 2021-2026 (K Units) by Country
Table 115. Global Off-body Wearable Injectors Consumption (K Units) Forecast by Regions (2021-2026)
Table 116. Global Off-body Wearable Injectors Production (K Units) Forecast by Type (2021-2026)
Table 117. Global Off-body Wearable Injectors Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Off-body Wearable Injectors Price (US$/Unit) Forecast by Type (2021-2026)
Table 119. Global Off-body Wearable Injectors Consumption (K Units) Forecast by Application (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Off-body Wearable Injectors
Figure 2. Global Off-body Wearable Injectors Production Market Share by Type: 2020 VS 2026
Figure 3. Electronical Injectors Product Picture
Figure 4. Mechanical Injectors Product Picture
Figure 5. Others Product Picture
Figure 6. Global Off-body Wearable Injectors Consumption Market Share by Application: 2020 VS 2026
Figure 7. Immuno-oncology
Figure 8. Diabetes
Figure 9. Cardiovascular Diseases
Figure 10. Other
Figure 11. North America Off-body Wearable Injectors Revenue (Million US$) and Growth Rate (2015-2026)
Figure 12. Europe Off-body Wearable Injectors Revenue (Million US$) and Growth Rate (2015-2026)
Figure 13. China Off-body Wearable Injectors Revenue (Million US$) and Growth Rate (2015-2026)
Figure 14. Japan Off-body Wearable Injectors Revenue (Million US$) and Growth Rate (2015-2026)
Figure 15. Global Off-body Wearable Injectors Revenue (Million US$) (2015-2026)
Figure 16. Global Off-body Wearable Injectors Production Capacity (K Units) (2015-2026)
Figure 17. Off-body Wearable Injectors Production Share by Manufacturers in 2019
Figure 18. Global Off-body Wearable Injectors Revenue Share by Manufacturers in 2019
Figure 19. Off-body Wearable Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Market Off-body Wearable Injectors Average Price (US$/Unit) of Key Manufacturers in 2019
Figure 21. The Global 5 and 10 Largest Players: Market Share by Off-body Wearable Injectors Revenue in 2019
Figure 22. Global Off-body Wearable Injectors Production Market Share by Region (2015-2020)
Figure 23. Global Off-body Wearable Injectors Production Market Share by Region in 2019
Figure 24. Global Off-body Wearable Injectors Revenue Market Share by Region (2015-2020)
Figure 25. Global Off-body Wearable Injectors Revenue Market Share by Region in 2019
Figure 26. Global Off-body Wearable Injectors Production (K Units) Growth Rate (2015-2020)
Figure 27. North America Off-body Wearable Injectors Production (K Units) Growth Rate (2015-2020)
Figure 28. Europe Off-body Wearable Injectors Production (K Units) Growth Rate (2015-2020)
Figure 29. China Off-body Wearable Injectors Production (K Units) Growth Rate (2015-2020)
Figure 30. Japan Off-body Wearable Injectors Production (K Units) Growth Rate (2015-2020)
Figure 31. Global Off-body Wearable Injectors Consumption Market Share by Region (2015-2020)
Figure 32. Global Off-body Wearable Injectors Consumption Market Share by Region in 2019
Figure 33. North America Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 34. North America Off-body Wearable Injectors Consumption Market Share by Countries in 2019
Figure 35. Canada Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 37. Europe Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 38. Europe Off-body Wearable Injectors Consumption Market Share by Countries in 2019
Figure 39. Germany America Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 40. France Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 41. U.K. Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 42. Italy Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 43. Russia Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 44. Asia Pacific Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 45. Asia Pacific Off-body Wearable Injectors Consumption Market Share by Regions in 2019
Figure 46. China Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 47. Japan Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 49. Taiwan Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 50. Southeast Asia Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 51. India Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 52. Australia Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 53. Latin America Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 54. Latin America Off-body Wearable Injectors Consumption Market Share by Countries in 2019
Figure 55. Mexico Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 56. Brazil Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 57. Production Market Share of Off-body Wearable Injectors by Type (2015-2020)
Figure 58. Production Market Share of Off-body Wearable Injectors by Type in 2019
Figure 59. Revenue Share of Off-body Wearable Injectors by Type (2015-2020)
Figure 60. Revenue Market Share of Off-body Wearable Injectors by Type in 2019
Figure 61. Global Off-body Wearable Injectors Production Growth by Type (2015-2020) (K Units)
Figure 62. Global Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
Figure 63. Global Off-body Wearable Injectors Consumption Market Share by Application in 2019
Figure 64. Global Off-body Wearable Injectors Consumption Growth Rate by Application (2015-2020)
Figure 65. Price Trend of Key Raw Materials
Figure 66. Manufacturing Cost Structure of Off-body Wearable Injectors
Figure 67. Manufacturing Process Analysis of Off-body Wearable Injectors
Figure 68. Off-body Wearable Injectors Industrial Chain Analysis
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. Porter's Five Forces Analysis
Figure 72. Global Off-body Wearable Injectors Production Capacity (K Units) and Growth Rate Forecast (2021-2026)
Figure 73. Global Off-body Wearable Injectors Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 74. Global Off-body Wearable Injectors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 75. Global Off-body Wearable Injectors Price and Trend Forecast (2021-2026)
Figure 76. Global Off-body Wearable Injectors Production Market Share Forecast by Region (2021-2026)
Figure 77. North America Off-body Wearable Injectors Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 78. North America Off-body Wearable Injectors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 79. Europe Off-body Wearable Injectors Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 80. Europe Off-body Wearable Injectors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 81. China Off-body Wearable Injectors Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 82. China Off-body Wearable Injectors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 83. Japan Off-body Wearable Injectors Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 84. Japan Off-body Wearable Injectors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 85. Global Forecasted and Consumption Demand Analysis of Off-body Wearable Injectors
Figure 86. North America Off-body Wearable Injectors Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 87. Europe Off-body Wearable Injectors Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 88. Asia Pacific Off-body Wearable Injectors Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 89. Latin America Off-body Wearable Injectors Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 90. Global Off-body Wearable Injectors Production (K Units) Forecast by Type (2021-2026)
Figure 91. Global Off-body Wearable Injectors Revenue Market Share Forecast by Type (2021-2026)
Figure 92. Global Off-body Wearable Injectors Consumption Forecast by Application (2021-2026)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 1. Picture of Off-body Wearable Injectors
Figure 2. Global Off-body Wearable Injectors Production Market Share by Type: 2020 VS 2026
Figure 3. Electronical Injectors Product Picture
Figure 4. Mechanical Injectors Product Picture
Figure 5. Others Product Picture
Figure 6. Global Off-body Wearable Injectors Consumption Market Share by Application: 2020 VS 2026
Figure 7. Immuno-oncology
Figure 8. Diabetes
Figure 9. Cardiovascular Diseases
Figure 10. Other
Figure 11. North America Off-body Wearable Injectors Revenue (Million US$) and Growth Rate (2015-2026)
Figure 12. Europe Off-body Wearable Injectors Revenue (Million US$) and Growth Rate (2015-2026)
Figure 13. China Off-body Wearable Injectors Revenue (Million US$) and Growth Rate (2015-2026)
Figure 14. Japan Off-body Wearable Injectors Revenue (Million US$) and Growth Rate (2015-2026)
Figure 15. Global Off-body Wearable Injectors Revenue (Million US$) (2015-2026)
Figure 16. Global Off-body Wearable Injectors Production Capacity (K Units) (2015-2026)
Figure 17. Off-body Wearable Injectors Production Share by Manufacturers in 2019
Figure 18. Global Off-body Wearable Injectors Revenue Share by Manufacturers in 2019
Figure 19. Off-body Wearable Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Market Off-body Wearable Injectors Average Price (US$/Unit) of Key Manufacturers in 2019
Figure 21. The Global 5 and 10 Largest Players: Market Share by Off-body Wearable Injectors Revenue in 2019
Figure 22. Global Off-body Wearable Injectors Production Market Share by Region (2015-2020)
Figure 23. Global Off-body Wearable Injectors Production Market Share by Region in 2019
Figure 24. Global Off-body Wearable Injectors Revenue Market Share by Region (2015-2020)
Figure 25. Global Off-body Wearable Injectors Revenue Market Share by Region in 2019
Figure 26. Global Off-body Wearable Injectors Production (K Units) Growth Rate (2015-2020)
Figure 27. North America Off-body Wearable Injectors Production (K Units) Growth Rate (2015-2020)
Figure 28. Europe Off-body Wearable Injectors Production (K Units) Growth Rate (2015-2020)
Figure 29. China Off-body Wearable Injectors Production (K Units) Growth Rate (2015-2020)
Figure 30. Japan Off-body Wearable Injectors Production (K Units) Growth Rate (2015-2020)
Figure 31. Global Off-body Wearable Injectors Consumption Market Share by Region (2015-2020)
Figure 32. Global Off-body Wearable Injectors Consumption Market Share by Region in 2019
Figure 33. North America Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 34. North America Off-body Wearable Injectors Consumption Market Share by Countries in 2019
Figure 35. Canada Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 37. Europe Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 38. Europe Off-body Wearable Injectors Consumption Market Share by Countries in 2019
Figure 39. Germany America Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 40. France Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 41. U.K. Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 42. Italy Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 43. Russia Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 44. Asia Pacific Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 45. Asia Pacific Off-body Wearable Injectors Consumption Market Share by Regions in 2019
Figure 46. China Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 47. Japan Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 49. Taiwan Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 50. Southeast Asia Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 51. India Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 52. Australia Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 53. Latin America Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 54. Latin America Off-body Wearable Injectors Consumption Market Share by Countries in 2019
Figure 55. Mexico Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 56. Brazil Off-body Wearable Injectors Consumption Growth Rate (2015-2020) (K Units)
Figure 57. Production Market Share of Off-body Wearable Injectors by Type (2015-2020)
Figure 58. Production Market Share of Off-body Wearable Injectors by Type in 2019
Figure 59. Revenue Share of Off-body Wearable Injectors by Type (2015-2020)
Figure 60. Revenue Market Share of Off-body Wearable Injectors by Type in 2019
Figure 61. Global Off-body Wearable Injectors Production Growth by Type (2015-2020) (K Units)
Figure 62. Global Off-body Wearable Injectors Consumption Market Share by Application (2015-2020)
Figure 63. Global Off-body Wearable Injectors Consumption Market Share by Application in 2019
Figure 64. Global Off-body Wearable Injectors Consumption Growth Rate by Application (2015-2020)
Figure 65. Price Trend of Key Raw Materials
Figure 66. Manufacturing Cost Structure of Off-body Wearable Injectors
Figure 67. Manufacturing Process Analysis of Off-body Wearable Injectors
Figure 68. Off-body Wearable Injectors Industrial Chain Analysis
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. Porter's Five Forces Analysis
Figure 72. Global Off-body Wearable Injectors Production Capacity (K Units) and Growth Rate Forecast (2021-2026)
Figure 73. Global Off-body Wearable Injectors Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 74. Global Off-body Wearable Injectors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 75. Global Off-body Wearable Injectors Price and Trend Forecast (2021-2026)
Figure 76. Global Off-body Wearable Injectors Production Market Share Forecast by Region (2021-2026)
Figure 77. North America Off-body Wearable Injectors Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 78. North America Off-body Wearable Injectors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 79. Europe Off-body Wearable Injectors Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 80. Europe Off-body Wearable Injectors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 81. China Off-body Wearable Injectors Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 82. China Off-body Wearable Injectors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 83. Japan Off-body Wearable Injectors Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 84. Japan Off-body Wearable Injectors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 85. Global Forecasted and Consumption Demand Analysis of Off-body Wearable Injectors
Figure 86. North America Off-body Wearable Injectors Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 87. Europe Off-body Wearable Injectors Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 88. Asia Pacific Off-body Wearable Injectors Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 89. Latin America Off-body Wearable Injectors Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 90. Global Off-body Wearable Injectors Production (K Units) Forecast by Type (2021-2026)
Figure 91. Global Off-body Wearable Injectors Revenue Market Share Forecast by Type (2021-2026)
Figure 92. Global Off-body Wearable Injectors Consumption Forecast by Application (2021-2026)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
